ATHLETICS: Asafa Powell's drug hearing resumes today
The drug hearing into the positive test of former 100-metre world record holder Asafa Powell will resume this morning at the Jamaica Conference Centre in Kingston.
The hearing was originally schedule to be completed on January 15 but a further two days were requested in order to hear from other key witnesses.
As a result of the extra two days, the hearing is now set to wrap up tomorrow.
The 31-year-old Powell is facing a disciplinary panel following his positive test for the banned stimulant Oxilofrine at the national championships last June.
Powell blamed the positive tests on a new brand of nutritional supplements given to him by his physical trainer, Canadian Chris Xuereb.
During the disciplinary hearing last month, Powell admitted that he had failed to disclose all the supplements he was taking on his “doping control form” because he could not remember their names.
Powell said he was given nine nutritional supplements to take by Xuereb, but he recorded only three of them on his form because the others were new to him and he could not recall the brand names.
Among the products Powell failed to disclose was Epiphany D1, which his management company claim was the source of the oxilofrine.
However, Dr Wayne McLaughlin, a professor in Biochemistry at the University of the West Indies, testified that the banned stimulant Oxilofrine found in the sprinter’s body was minimal.
Professor McLaughlin told the disciplinary panel that it was unlikely that the quantity of Oxilofrine found in the athlete’s urine could enhance his performance.
Powell is among five Jamaican athletes who failed drugs tests at the national championships last year.
FOR MORE STORIES WATCH: